Rebright Partners — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Essenviaessenvia.cominMar 2023
Essenvia offers a regulatory information management platform for medical device regulatory affairs teams, automating submissions (including FDA eSTAR), centralizing registrations, and providing AI-driven regulatory intelligence and lifecycle tracking.
AI & Machine LearningMedical DevicesSaaSWoodland Hills, US
Basant Sahoo(Director)Soumya Mahapatra(Executive Officer, Director)
Co-investorsArka Venture LabsExpert DOJOBenhamou Global VenturesWavemaker Three-Sixty Health
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.